Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;55(1):8-14.
doi: 10.4103/0019-5154.60343.

Botulinum toxin

Affiliations

Botulinum toxin

P K Nigam et al. Indian J Dermatol. 2010.

Abstract

Botulinum toxin, one of the most poisonous biological substances known, is a neurotoxin produced by the bacterium Clostridium botulinum. C. botulinum elaborates eight antigenically distinguishable exotoxins (A, B, C(1), C(2), D, E, F and G). All serotypes interfere with neural transmission by blocking the release of acetylcholine, the principal neurotransmitter at the neuromuscular junction, causing muscle paralysis. The weakness induced by injection with botulinum toxin A usually lasts about three months. Botulinum toxins now play a very significant role in the management of a wide variety of medical conditions, especially strabismus and focal dystonias, hemifacial spasm, and various spastic movement disorders, headaches, hypersalivation, hyperhidrosis, and some chronic conditions that respond only partially to medical treatment. The list of possible new indications is rapidly expanding. The cosmetological applications include correction of lines, creases and wrinkling all over the face, chin, neck, and chest to dermatological applications such as hyperhidrosis. Injections with botulinum toxin are generally well tolerated and side effects are few. A precise knowledge and understanding of the functional anatomy of the mimetic muscles is absolutely necessary to correctly use botulinum toxins in clinical practice.

Keywords: Botulinum toxin; Clostridium botulinum; adverse effects; clinical applications.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

References

    1. Münchau A, Bhatia KP. Uses of botulinum toxin injection in medicine today. BMJ. 2000;320:161–5. - PMC - PubMed
    1. Scott AB. Botulinum toxin injection of eye muscles to correct strabismus. Trans Trans Am Ophthalmol Soc. 1981;79:734–70. - PMC - PubMed
    1. Ellenhorn MJ, Barceloux DG, editors. Diagnosis and Treatment of Human Poisoning. New York: Elsevier; 1988. Medical Toxicology; pp. 1185–7.
    1. Brin MF. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl. 1997;20:146–68. - PubMed
    1. Sellin LC. The pharmacological mechanism of botulism. Trends Pharmacol Sci. 1985;6:80–2.